Our vision at MiProbes is to enable accessible, trusted and personalized health tracking for all. This to complete our mission of preventing serious health conditions from arising. At MiProbes we also want to empower and educate people to know what healthy means to them.
We believe that in the future, we will measure and track not just our heart rates and step count, but many more biomarkers that can detect serious health disorders early, before any symptoms appear. This will allow us to leave longer and healthier lives. MiProbes is the first step to this future, bringing diagnostics tests to your home, enabling testing anywhere, by anyone at any-time. We want to armed you with data on your body's health, to allow you to make data-driven day-to-day lifestyle decisions to optimize your health.
Each customer of MiProbes will create data specific to their bodies. Over time, this data will help you identify trends that are unique to you. This way, any changes to your health that might typically go unnoticed in your day-to-day life, or even at your occasional visits to the doctor, will be impossible to miss through health tracking.
The days of having your health compared to an “average” on a difficult to read medical chart are over. You deserve to know what healthy means to you specifically. MiProbes is here to help.
CEO & Co-Founder
Dr. Nina Patrick
Dr. Nina Patrick is a health-curious scientist with a PhD in Bioengineering and Pharmaceutical Studies. In her PhD, Nina identified specific hormone imbalances caused by pharmaceutical drugs. She was driven to start this company to help these patients to learn of these imbalances and deficiencies in the comfort of their own home.
Dr. Augusta Modestino
CSO & Co-Founder
Dr. Augusta Modestino, also holds a PhD in Bioengineering from UCSD. Her expertise is in diagnostic assay tech-development. During her PhD, Augusta developed point-of-care diagnostic assays for coagulation and metabolic disorders. Augusta worked at Knight Cancer Institute at Oregon Health and Science University to develop technologies to enable early-cancer detection.